ABT · 10-Q · 2026Q3 · Full report

EP and Rhythm Management Growth

ABBOTT LABORATORIES · 2026-11-04 · Importance 36 · Surprise 40

For the first nine months of 2026, Electrophysiology sales increased 13.8% excluding foreign exchange, primarily reflecting increased sales of ablation catheters and related portfolio products. Rhythm Management sales increased 10.6% excluding foreign exchange, primarily due to growth in Aveir leadless pacemakers. These growth rates exceed 10%, while the filing attributes them to higher sales of Abbott products rather than providing market-wide growth or share data.

Key facts

• Electrophysiology sales increased 13.8% excluding foreign exchange in the first nine months of 2026, primarily reflecting increased sales of ablation catheters and related products. source
• Rhythm Management sales increased 10.6% excluding foreign exchange in the first nine months of 2026, primarily due to growth in Aveir leadless pacemakers. source